SCHEMBL22258685

SCHEMBL22258685

Clc1nc(-c2ccc3ccccc3c2)c2ccc3sc4ccc5ccccc5c4c3c2n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.36
CYP1B1 Q16678 5/20 0.36
CYP1A2 P05177 4/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 4/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
NQO2 P16083 2/20 0.33
NQO1 P15559 1/20 0.33
HTR2B P41595 1/20 0.33
HTR5A P47898 1/20 0.33
MAPT P10636 4/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LMNA P02545 2/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22259099 0.90 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL22258684 0.89 LMNA (0.41) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL22258322 0.88 RPA1 (0.34) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL18553269 0.84 MAPK8 (0.35) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL18132499 0.83 MAPT (0.46) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL22258720 0.82 CYP1A1 (0.34) CYP1A1CYP1B1CYP1A2ALDH1A1MAPK8
SCHEMBL22258682 0.80 MAPT (0.37) CYP1A1CYP1B1CYP1A2ALDH1A1NQO2
SCHEMBL19660683 0.80 MAPT (0.40) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL22258673 0.79 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL22258781 0.78 ALDH1A1 (0.35) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11211568-B2 Compound for organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-12-28 US disclosed
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11211568-B2 Compound for organic electroluminescence device using the same OR10J3, PIEZO1, ICMT CYP1A1 1338/4885CYP1B1 1612/4885CYP1A2 1343/4885
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ICMT CYP1A1 1338/4885CYP1B1 1612/4885CYP1A2 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.